EUVIMEDEUVIMED entdecken
Crossref

Semiconducting Titanate Supported Ruthenium Clusterzymes for Ultrasound‐Amplified Biocatalytic Tumor Nanotherapies

Huang Zhu, Jiuhong Deng, Minjia Yuan, Xiao Rong, Xi Xiang, Fangxue Du, Xianglin Luo, Chong Cheng iD, Li Qiu

Small · 2023

DOI: 10.1002/smll.202206911 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2023. Verfasst von Huang Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Polymer Science and Engineering, Med-X Center for Materials, State Key Laboratory of Polymer Materials Engineering, Sichuan University, Ch…. Hauptthemen laut MEDLINE: Ruthenium, Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The external‐stimulation‐induced reactive‐oxygen‐species (ROS) generation has attracted increasing attention in therapeutics for malignant tumors. However, engineering a nanoplatform that integrates with efficient biocatalytic ROS generation, ultrasound‐amplified ROS production, and simultaneous relief of tumor hypoxia is still a great challenge. Here, we create new semiconducting titanate‐supported Ru clusterzymes (RuNC/BTO) for ultrasound‐amplified biocatalytic tumor nanotherapies. The morphology and chemical/electronic structure analysis prove that the biocatalyst consists of Ru nanoclusters that are tightly stabilized by Ru‐O coordination on BaTiO 3 . The peroxidase (POD)‐ and halogenperoxidase‐like biocatalysis reveals that the RuNC/BTO can produce abundant •O 2 − radicals. Notably, the RuNC/BTO exhibits the highest turnover number (63.29 × 10 −3 s −1 ) among the state‐of‐the‐art POD‐mimics. Moreover, the catalase‐like activity of the RuNC/BTO facilitates the decomposition of H 2 O 2 to produce O 2 for relieving the hypoxia of the tumor and amplifying the ROS level via ultrasound irradiation. Finally, the systematic cellular and animal experiments have validated that the multi‐modal strategy presents superior tumor cell‐killing effects and suppression abilities. We believe that this work will offer an effective clusterzyme that can adapt to the tumor microenvironment‐specific catalytic therapy and also provide a new pathway for engineering high‐performance ROS production materials across broad therapeutics and biomedical fields.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RutheniumNeoplasmsAnimalsBiocatalysisReactive Oxygen SpeciesUltrasonographyPeroxidasePeroxidasesColoring AgentsOxygenTumor MicroenvironmentCell Line, Tumor

Stichwörter der Autor:innen

clusterzymesreactive oxygen speciessemiconducting titanatetumor nanotherapiesultrasound

Substanzen

Reactive Oxygen SpeciesRutheniumPeroxidasePeroxidasesColoring AgentsOxygen

Autor:innen und Institutionen

  • College of Polymer Science and Engineering, Med-X Center for Materials, State Key Laboratory of Polymer Materials Engineering, Sichuan University, Chengdu, 610065, China.
  • West China Hospital of Stomatology, Sichuan University, Chengdu, 610041, China.
  • Department of Ultrasound, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, 610041, China.

ORCID-Profile: Chong Cheng

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhu, H., Deng, J., Yuan, M., Rong, X., Xiang, X., Du, F., Luo, X., Cheng, C., & Qiu, L. (2023). Semiconducting Titanate Supported Ruthenium Clusterzymes for Ultrasound‐Amplified Biocatalytic Tumor Nanotherapies. Small. https://doi.org/10.1002/smll.202206911

Vancouver

Zhu H, Deng J, Yuan M, Rong X, Xiang X, Du F, et al. Semiconducting Titanate Supported Ruthenium Clusterzymes for Ultrasound‐Amplified Biocatalytic Tumor Nanotherapies. Small. 2023. doi:10.1002/smll.202206911

BibTeX
@article{Zhu2023,
  author = {Zhu, Huang and Deng, Jiuhong and Yuan, Minjia and Rong, Xiao and Xiang, Xi and Du, Fangxue and Luo, Xianglin and Cheng, Chong and Qiu, Li},
  title = {Semiconducting Titanate Supported Ruthenium Clusterzymes for Ultrasound‐Amplified Biocatalytic Tumor Nanotherapies},
  journal = {Small},
  year = {2023},
  doi = {10.1002/smll.202206911}
}
Kostenlos starten →